18 European techbio investors that founders should know
Meet the most active investors in the European techbio scene — a challenging but rewarding sector for the VCs that are able to get into it
Stay updated with breaking news from Tailor Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Meet the most active investors in the European techbio scene — a challenging but rewarding sector for the VCs that are able to get into it
15.06.2022 - Scientists have found a way to identify and interpret -signatures- that reveal the complex genetic causes of some of the deadliest cancers - which often have a survival rate of less than 10%. The results could allow them to develop more accurate treatments and significantly improve survival rates.
Scientists have found a way to identify and interpret 'signatures' that reveal the complex genetic causes of some of the deadliest cancers – which often have a survival rate of less than 10%.
Scientists have found a way to identify and interpret ‘signatures’ that reveal the complex genetic causes of some of the deadliest cancers – which often have a survival rate of less than 10%. The results, published today in Nature, could allow them to develop more accurate treatments and significantly improve survival rates.